Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine

Conditions

• Tetanus, Diphtheria and Acellular Pertussis Vaccination
• Tetanus
• Diphtheria
• Pertussis
• Pertussis Vaccines

Interventions

• BIOLOGICAL: low-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content)
• BIOLOGICAL: high-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content)
• BIOLOGICAL: Tetanus, Diphtheria and Acellular Pertussis Vaccine
• BIOLOGICAL: 23-valent polysaccharide pneumococcal vaccine

Sponsor

Institute of Medical Biology, Chinese Academy of Medical Sciences